Result of Meeting
Trellus Health PLC announced that all resolutions presented at its General Meeting on January 20, 2026, were passed with overwhelming support, with votes in favour ranging from 99.87% to 99.90%. This indicates strong shareholder confidence in the company's proposed actions, which are crucial for its ongoing operations and strategic direction.
Select text to share a quote on X · sign in to keep highlights & notes in your TRLS notes
LONDON, U.K. AND NEW YORK, U.S. (20 January 2026). Trellus Health® plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programs and value-based solutions to manage complex chronic conditions, announces that at the General Meeting ("GM") held earlier today, all resolutions, as set out in the GM notice published on 31 December 2025, were duly passed on a poll.
The voting results of the GM were as follows:
| In Favour | Against | Withheld | ||||
|---|---|---|---|---|---|---|
| Resolution | Type | Votes | % | Votes | % | Votes |
| 1 | Ordinary | 68,221,782 | 99.90 | 71,031 | 0.10 | 4,625 |
| 2 | Special | 68,217,291 | 99.89 | 76,004 | 0.11 | 4,143 |
| 3 | Ordinary | 68,221,782 | 99.90 | 71,031 | 0.10 | 4,625 |
| 4 | Special | 68,206,212 | 99.87 | 87,083 | 0.13 | 4,143 |
| 5 | Special | 68,206,212 | 99.87 | 87,083 | 0.13 | 4,143 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.